Skip to content

Drug interactions

Atazanavir + Eltrombopag

Severity: Moderate

Atazanavir and Eltrombopag: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atazanavir inhibits UGT1A1, and eltrombopag is partly cleared by UGT1A1 and UGT1A3. Eltrombopag exposure may rise, and both drugs can raise bilirubin and liver enzymes.

What this interaction means in plain words

Atazanavir and Eltrombopag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atazanavir belongs to Anti Virals; Eltrombopag belongs to Miscellaneous.

Evidence level: Low

Why it happens

Atazanavir inhibits UGT1A1 and possibly CYP-mediated clearance, which may reduce eltrombopag elimination.

What to do

Monitor liver function tests and bilirubin and review platelet response. Adjust the eltrombopag dose if hepatic abnormalities or excessive platelet counts occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atazanavir and Eltrombopag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Atazanavir with Eltrombopag?

MediHelp rates the interaction as moderate. Atazanavir and Eltrombopag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Atazanavir inhibits UGT1A1, and eltrombopag is partly cleared by UGT1A1 and UGT1A3. Eltrombopag exposure may rise, and both drugs can raise bilirubin and liver enzymes.

How serious is the interaction between Atazanavir and Eltrombopag?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver function tests and bilirubin and review platelet response. Adjust the eltrombopag dose if hepatic abnormalities or excessive platelet counts occur.

What other medicines interact with Eltrombopag?

MediHelp also lists interactions of Eltrombopag with, for example, Alpelisib, Aluminum hydroxide, Amobarbital. The full list is on the Eltrombopag page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in